comparemela.com

Latest Breaking News On - Brad miles - Page 1 : comparemela.com

HUTCHMED Reports 2023 Interim Results and Provides Business Updates

HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study

HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 20, 2023 (GLOBE NEWSWIRE) HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that the Center for Drug

HUTCHMED Announces Changes to Board of Directors and Technical Committee

HUTCHMED Announces Changes to Board of Directors and Technical Committee  Ms Ling Yang to replace Mr Lefei Sun as Non-executive Director; Professor Solange Peters appointed as Special Advisor to the Technical Committee Hong Kong, Shanghai & Florham Park, NJ — Thursday, July 13, 2023: HU.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.